Email updates

Keep up to date with the latest news and content from Microbial Cell Factories and BioMed Central.

Open Access Highly Accessed Research

Application of a wide-range yeast vector (CoMed™) system to recombinant protein production in dimorphic Arxula adeninivorans, methylotrophic Hansenula polymorpha and other yeasts

Gerhard Steinborn1, Erik Böer1, Anja Scholz1, Kristina Tag1, Gotthard Kunze1* and Gerd Gellissen2

Author Affiliations

1 Institut für Pflanzengenetik und Kulturpflanzenforschung, Corrensstr. 3, 06466 Gatersleben, Germany

2 PharmedArtis GmbH, Forckenbeckstr. 6, D-52074 Aachen, Germany

For all author emails, please log on.

Microbial Cell Factories 2006, 5:33  doi:10.1186/1475-2859-5-33

The electronic version of this article is the complete one and can be found online at:

Received:21 September 2006
Accepted:14 November 2006
Published:14 November 2006

© 2006 Steinborn et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.



Yeasts provide attractive expression platforms in combining ease of genetic manipulation and fermentation of a microbial organism with the capability to secrete and to modify proteins according to a general eukaryotic scheme. However, early restriction to a single yeast platform can result in costly and time-consuming failures. It is therefore advisable to assess several selected systems in parallel for the capability to produce a particular protein in desired amounts and quality. A suitable vector must contain a targeting sequence, a promoter element and a selection marker that function in all selected organisms. These criteria are fulfilled by a wide-range integrative yeast expression vector (CoMed™) system based on A. adeninivorans- and H. polymorpha-derived elements that can be introduced in a modular way.


The vector system and a selection of modular elements for vector design are presented. Individual single vector constructs were used to transform a range of yeast species. Various successful examples are described. A vector with a combination of an rDNA sequence for genomic targeting, the E. coli-derived hph gene for selection and the A. adeninivorans-derived TEF1 promoter for expression control of a GFP (green fluorescent protein) gene was employed in a first example to transform eight different species including Hansenula polymorpha, Arxula adeninivorans and others. In a second example, a vector for the secretion of IL-6 was constructed, now using an A. adeninivorans-derived LEU2 gene for selection of recombinants in a range of auxotrophic hosts. In this example, differences in precursor processing were observed: only in A. adeninivorans processing of a MFα1/IL-6 fusion was performed in a faithful way.


rDNA targeting provides a tool to co-integrate up to 3 different expression plasmids by a single transformation step. Thus, a versatile system is at hand that allows a comparative assessment of newly introduced metabolic pathways in several organisms or a comparative co-expression of bottleneck genes in cases where production or secretion of a certain product is impaired.


The exploitation of recombinant DNA technology to engineer expression systems for heterologous protein production provided a major task during the last decades. Production procedures had to be developed that employ platforms which meet both the demand for efficient mass production and criteria of safety and authenticity of the produced compounds [1,2]. In this respect, yeasts offer considerable advantages over alternative microbial and eukaryotic cellular systems in providing low-cost screening and production systems for authentically processed and modified compounds. These organisms furthermore meet safety prerequisites in that they do not harbour pyrogens, pathogens or viral inclusions.

The initial yeast system developed for heterologous gene expression was based on the baker's yeast Saccharomyces cerevisiae. This platform has been successfully applied to the production of various FDA-approved pharmaceuticals including insulin [3] and HBsAg [4]. However, when using this system, certain limitations and drawbacks are often encountered, since S. cerevisiae tends to hyperglycosylate recombinant proteins; N-linked carbohydrate chains are terminated by mannose attached to the chain via an α1,3 bond, which is considered to be allergenic. Other restrictions are the consequence of the limited variety of carbon sources that can be utilised by this species, which limits the fermentation design options. Sometimes, the preferential use of episomal vectors leads to instabilities of recombinant strains; as a result, batch inconsistencies of production runs can be of major concern [2].

Therefore, alternative yeast systems have been defined that can potentially overcome the described limitations of the traditional baker's yeast. Examples include the two methylotrophic yeast species Hansenula polymorpha [5,6] and Pichia pastoris [5,7], the dimorphic organism Arxula adeninivorans [8,9] and others. These organisms share the capability to utilize a broad range of carbon sources, two of them (H. polymorpha and A. adeninivorans) can assimilate nitrate and are thermotolerant species, with the latter exhibiting a temperature-dependent dimorphism with hyphae formed at elevated temperature and alterations in the extent of O glycosylation. For all systems, a range of host strains and relevant genetic elements are available.

In case of the two methylotrophic species, engineered strains have been developed that exhibit human-like N-glycosylation patterns [6,7,10,11]. The genome of both species has been completely deciphered [6,7,12], and for H. polymorpha a microarray chip is available [13]. In case of dimorphic A. adeninivorans species, data on chromosomes and on a partial characterization of the genomes are already available [9]. A more detailed description of some of the platforms can be found in [14] and in a recent book on production of recombinant proteins and various chapters therein [1,2,6,7,9,15].

Despite the superior characteristics of yeast hosts in various developments, there is clearly no single system that is optimal for production of all possible proteins. Predictions of a successful development for a given protein can only be made to a certain extent when restricting the initial strain engineering to a single species. The availability of a wide-range yeast vector system enables the assessment of several yeasts in parallel for their capability to produce a particular protein in desired amounts and quality [16-18]. Examples for the application of such vectors are provided in the following overview.

Results and discussion

1. Design and optimization of the CoMed™ vector system

Since vector systems of different yeast species are based on different basic vectors it is very difficult to exchange single cassettes between the yeast systems. To reduce this disadvantage the CoMed™ vector system was established containing the pCoMed™ basic vector for integration of ARS, selection markers, rDNA sequences and expression cassettes. For this purpose, the single modules are flanked by identical restriction sites and are integrated in the same location of the basic vector. In this system, various modules can be integrated. A selection of rDNA elements derived from the A. adeninivorans or H. polymorpha clusters has been assessed for suitability as targeting sequences. Particular elements of both clusters derived from an ETS-18S – 5.8S segment were found to be optimal. Due to high conservation of the included coding regions targeting of all yeast species is feasible [19]. If for instance the combination of rDNA and the ALEU2 gene is chosen, a range of yeasts with this auxotrophy can be targeted. The same holds for the insertion of a dominant selection marker like the E.coli-derived hph gene conferring resistance to hygromycin B in all yeast species tested so far. The expression cassette is inserted in a final step as fragments derived from pre-constructed plasmids. A range of such cassette elements exists harbouring a promoter of choice, among others the A. adeninivorans-derived TEF1 promoter mentioned before, and a S. cerevisiae PHO5 terminator separated by a multiple cloning site. Again, this promoter was found to be functional in all yeast species tested so far [20,21]. A selection of ARS sequences is available that will result in either episomal (S. cerevisiae) or chromosomally integrated plasmids (Hansenula polymorpha). However inclusion of such a sequence may reduce the range of addressible hosts.

By easy exchange of modules, such a vector can be converted into a plasmid that is optimal for an individual platform, for instance by inserting an expression cassette with a MOX promoter element that elicits efficient gene expression in methylotrophic yeasts only. The general design of the plasmid CoMed™ with a selection of components is provided in Fig. 1 and Tab. 1, additional elements and a range of available host strains based on different species can be found in [14]. Variants of this basic vector for the production of antibodies and derivatives thereof are under development. In yet another design, it is possible to linearize the plasmids in a way that leaves behind all bacterial DNA sequences.

Table 1. ARS, rDNA regions, selection markers and promoter elements of the CoMed™ vector system.

thumbnailFigure 1. Design and functionality of CoMed™ vector system. The CoMed™ basic vector contains all E. coli elements for propagation in the E. coli system and a MCS for integration of ARS, rDNA, selection marker and expression cassette modules. For this purpose, ARS fragments are flanked by SacII and BcuI restriction sites, rDNA regions by BcuI and Eco47III restriction sites, selection markers by Eco47III and SalI restriction sites and promoter elements by SalI and ApaI restriction sites [38]).

2. Wide-range application of the CoMed™ vector system

In a first set of examples, we present the generation of recombinants based on a range of yeast species applying a single vector to transformation. In a first construct, a combination of elements was used that is suited to transform all yeast species tested so far, an rDNA-sequence for wide-range targeting and the E.coli-derived hph gene as dominant selection marker.

For proof of concept, an expression cassette was designed harbouring the Aequorea victoria-derived GFP gene inserted between the A. adeninivorans-derived TEF1 promoter and the PHO5 terminator of S. cerevisiae [18]. An arbitrary selection of yeast species was transformed by the vector linearized within the rDNA targeting sequence, namely S. cerevisiae, A. adeninivorans (budding cells and filamentous cells), H. polymorpha, Pichia pastoris, Debaryomyces polymorphus and D. hansenii. In all transformants, the heterologous DNA was observed to be mitotically stable integrated into the genome of the respective host. For GFP production, the transformants were cultured for 48 h in YEPD medium at 30°C and the produced GFP was detected by fluorescence microscopy. All transformants efficiently produced GFP as shown in Fig. 2. The GFP was distributed within the cytosol and excluded from the vacuoles.

thumbnailFigure 2. (A) Physical map of the expression/integration vector pAL-HPH-TEF-GFP used in this study. The vector contains the 25S rDNA sequence of A. adeninivorans (rDNA, white box) and an expression cassette for the E. coli-derived hph gene as selection marker in the order A. adeninivorans-derived TEF1 promoter (TEF1 pro,grey segment), the hph-coding sequence (HPH, grey segment), S. cerevisiae-derived PHO5 terminator (PHO5 ter, black bar). The vector further contains a second expression cassette with TEF1 promoter – GFP ORF – PHO5 terminator elements. The vector contains further an unique BglII site within the rDNA sequence for linearization. (B) Detection of recombinant GFP-producing yeast cells by fluorescence microscopy. Transformants were cultured for 48 h in YEPD medium at 30°C and subsequently used for fluorescence analysis. (I) transmission, (II) GFP-fluorescence.

In a second construct, we combined an rDNA targeting sequence and an A. adeninivorans-derived LEU2 [20] for selection. For comparative production, the cytokine IL-6, a secreted protein of industrial relevance, was selected. Recombinant expression systems for IL-6 have been established among others based on E. coli [38] and S. cerevisiae [39], in addition attempts have been described for H. polymorpha [40,41]. In both systems, production is hampered by N-terminal truncation of the product, elicited by a thiol protease that cleaves the mature protein at Arg8 (Arg9 in E. coli) [42]. For assessment, we inserted an expression cassette harbouring an ORF for a MFα1/IL-6 fusion protein under control of the elements described before and transformed leu2 auxotrophic strains of A. adeninivorans, H. polymorpha and S. cerevisiae. Again, mitotically stable strains were generated. Representatives of the three derived strain collections efficiently secreted the recombinant cytokine into the medium. In this case, product differences could be observed when comparing the secretion products of the different yeast species: the H. polymorpha and S. cerevisiae-derived molecules were found to be of smaller size than that secreted from the A. adeninivorans host. A more detailed comparative MS analysis of tryptic peptides revealed an N-terminal truncation at position Arg8 in H. polymorpha and S. cerevisiae, but a correctly processed mature IL-6 in A. adeninivorans (Fig. 3). This is probably due to the lack of a thiol protease in this dimorphic species. The result emphasizes the need of a careful early pre-selection of a platform for the development of a production process. A detailed description of comparative IL-6 production will be provided elsewhere.

thumbnailFigure 3. (A) Physical map of the expression/integration vector pAL-ALEU2m-TEF-MATalpha-IL6 used in this study. The vector contains the 25S rDNA sequence of A. adeninivorans (rDNA, white box), the selection marker ALEU2m (grey segment) and an expression cassette for the IL6 gene in the order A. adeninivorans-derived TEF1 promoter (TEF1 pro, grey segment), the IL6-coding sequence, S. cerevisiae-derived PHO5 terminator(PHO5 ter, black bar) as selection marker. The vector contains a unique NcoI site for linearization within the rDNA sequence. (B) IL6 accumulation in recombinant S. cerevisiae, A. adeninivorans budding cell and mycelia cultures as well as in H. polymorpha. The strains were cultured in YMM supplemented with 2% glucose for 72 h at 30°C (S. cerevisiae, A. adeninivorans budding cells, H. polymorpha) or 45°C (A. adeninivorans mycelia). 20 μl aliquots of culture media were separated on (11%) SDS-PAGE gels, transferred to nitrocellulose filters and probed with anti-IL-6 antibodies. The concentration of recombinant IL-6 was calculated from the signal intensity of a IL-6 standard. (1) IL-6 standard (E. coli), (2) A. adeninivorans G1211/pAL-ALEU2m-TEF-MATα-IL6 – budding cells (205 mg l-1), (3) A. adeninivorans G1211/pAL-ALEU2m-TEF-MATα-IL6 – mycelia (144 mg l-1), (4) S. cerevisiae SEY6210/pAL-ALEU2m-TEF-MATα-IL6 (95 mg l-1), (5) H. polymorpha HP102/pAL-ALEU2m-TEF-MATα-IL6 (90 mg l-1). (C) N-terminus of IL-6 secreted from recombinant S. cerevisiae, A. adeninivorans (budding cell and mycelial cultures) and from H. polymorpha strains.

3. Wide-range co-integration of different plasmids

It is possible to co-integrate multiple plasmids carrying expressible heterologous genes in the ribosomal DNA by a single transformation step [20,43]. Again, using appropriate selection markers and a functional wide-range promoter for expression control, a comparative single-step integration in a range of selected yeast platforms becomes feasible. In the following section, three promising examples are described.

3.1 Simultaneous introduction of a new metabolic pathway into different yeasts

In a first example, a new metabolic pathway was introduced into three different yeasts, namely D. polymorphus, D. hansenii and A. adeninivorans. For construction of recombinant biocatalysts, vectors were equipped with the genes phbA, phbB and phbC of the polyhydroxyalkanoate (PHA) biosynthetic pathway of Ralstonia eutropha encoding β-ketothiolase, NADPH-linked acetoacetyl-CoA reductase and PHA synthase under control of the A. adeninivorans-derived TEF1 promoter. Following the previous examples, the vectors were further equipped with an rDNA sequence and the E. coli-derived hph gene for wide-range integration and selection. Representatives of the three resulting strain collections were found to contain all three heterologous genes as single copies mitotically stable integrated into the genome. In fed-batch cultivations in minimal medium supplemented with 1% ethanol as carbon source, the recombinant yeasts were able to convert efficiently the substrates acetyl-CoA and propionyl-CoA to PHA (2.2% of dry weight) [[9,44]- Fig. 4].

thumbnailFigure 4. Transformation procedure based on simultaneous integration of the plasmids pAL-HPH-phbA-phbB and pAL-ALEU2m-phbC into the 25S rDNA of A. adeninivorans G1211 (aleu2). The two plasmids pAL-HPH-phbA-phbB and pAL-ALEU2m-phbC containing the expression cassettes with phbA, phbB and phbC genes are linearised by BglII or Esp3I digestion, respectively. The resulting fragments flanked by 25S rDNA sequences are co-integrated into the 25S rDNA by homologous recombination. Transformants are selected either by resistance to hygromycin B (plasmid pAL-HPH-phbA-phbB [25,44]) or the complementation of the aleu2 mutation (plasmid pAL-ALEU2m-phbC [20]).

3.2 Construction of an estrogen sensor based on recombinant A. adeninivorans cells

Recently, a novel estrogen biosensor based on recombinant A. adeninivorans cells has been developed. For this purpose, recombinant A. adeninivorans strains were engineered co-expressing the human estrogen receptor α(hERα) and a Klebsiella-derived phytase (phyK) reporter gene under control of an A. adeninivorans-derived glucoamylase (GAA) promoter modified by insertion of estrogen-responsive elements (EREs). In response to the presence of estrogenic compounds, hERα dimerizes, and subsequently, reporter gene expression is induced by binding of the newly generated hERα-dimer/estrogen complex to estrogen-responsive elements (ERE) within the promoter. The insertion of different numbers of EREs in three alternative promoter positions and its effect on reporter gene expression were assessed. In a particular construct, a detection limit of 5 ng l-1 and a quantification limit of 10 ng l-1 for 17β-estradiol-like activity could be achieved. A convenient photometric assay enables estrogen monitoring in sewage samples within 30 hrs ([45] – Fig. 5). As the two final plasmids are designed for wide-range transformation a range of other yeast species can now be assessed for this application.

thumbnailFigure 5. Principle of A. adeninivorans yeast estrogen sensor (A-YES). A. adeninivorans G1211 transformed with the plasmids pAL-HPH-hERα and pAL-ALEU2m-GAA(2xERE-107)-phyK (G1211/pAL-HPH-hERα – pAL-ALEU2m-GAA(2xERE-107)-phyK) was the bio component of the A-YES. It expresses the estrogen receptor gene (TEF1 promoter – hERα gene – PHO5-terminator) constitutively and produces a relatively constant level of recombinant hERα independent of the estrogen concentration. In the presence of estrogen or estrogen analogues, however, hERα forms a hERα-estrogen-dimer complex, which binds to the ERE-region of the GAA promoter located in the second reporter gene expression cassette. The cassette (GAA-ERE- promoter – phyK gene – PHO5 terminator) is activated, the phyK gene is expressed and phytase is synthesized. Since this enzyme contains a native signal sequence it is secreted and accumulates extracellularly. The recombinant phytase level is then quantified using a simple biochemical method.(C) Specificity of the A-YES based on A. adeninivorans G1211/pAL-HPH-hERα – pAL-ALEU2m-GAA(2xERE-107)-phyK for a range of steroids and steroid metabolites. The graphs depict the log concentration of 17α-ethynylestradiol (□), 17β-estradiol (■), estrone (▲), estriol (●), coumestrol (○) and bisphenol A (+) plotted against the recombinant phytase activity of the medium after 30 h incubation.

3.3 Assessment of secretory pathway genes for the production of IFNγ

IFNγ is produced by CD4 and CD8-positive T and NK (natural killer) cells. The mature protein consists of 146 amino acids. IFNγ is a potent anti-viral and anti-parasitic agent. It has been assessed for treatment of opportunistic infections in AIDS patients, for treatment of eosinophilia in severe atopic dermatitis and for treatment of osteopetrosis [46,47]. Two active forms of 25 and 20 kDa exist, differing in the extent of glycosylation. Glycosylation is not required for biological activity [48] but for proteolytic stability [49]. It is therefore desirable to have access to an efficient expression platform in which a cytokine can be produced as glycosylated protein. The protein has been produced in E. coli [50,51] and in mammalian cells [52].

IFNγ is poorly secreted from recombinant H. polymorpha cells in the form of hyperglycosylated molecules. In other examples, overexpression of secretory pathway genes has been shown to improve both, the yield and the quality of a recombinant product in several yeast platforms. Examples include the overexpression of KAR2 [53], PDI [54], SSO1/2 [55], CMK2 [56] and KEX2 [57]. However, it became apparent that the observed improvements were restricted to a specific recombinant product development in meeting the demands to overcome a particular limitation in the respective recombinant strains. When encountering such limitations like poor secretion, impaired processing or glycosylation, it seems advisable to assess several candidate genes of the secretion machinery or even combination thereof for an enhanced probability of success. A selection of four secretory pathway genes was assessed for possible impact on secretion improvements in this case. For assessment, wide-range rDNA integration vectors harbouring the H. polymorpha-derived KAR2, PDI, SSO2 or CNE1 genes [58] were co-integrated along with the IFNγ integration/expression vector. Overexpression of CNE1 resulted in an increased secretion of the cytokine predominantly consisting of molecules of distinct size. Deglycosylation with PNGaseF resulted in a Mr reduction of the secreted IFNγ corresponding to the removal of two N-linked glycoside chains. Coexpression of KAR2, PDI1 and SSO2 exhibited no effect (Fig. 6). Again, co-integration into alternative yeasts is now feasible. Furthermore a co-integration of the IFNγ gene with more than a single secretory pathway gene can be envisaged.

thumbnailFigure 6. Glycosylation analysis of secreted IFNγ. A strain of the pMrL-IFNg/pMrL-CNE collection was cultured on a 500 ml scale. The proteins of the supernatant were precipitated with (NH4)2SO4. An aliquot of the precipitate was digested with PNGase F as described in Materials and methods. Untreated and PNGase F-treated protein samples were compared to isolates from a previous strain collection. The various samples were separated by SDS-PAGE; proteins were visualized by immunoblotting as described before. (1,5,9,13) IFNγ standard (E.coli), (2,6,10,14) H. polymorpha, (3,4) H. polymorpha/CoMed8-MATα-IFNγ, (7,8) H. polymorpha/CoMed8-MATα-IFNγ – deglycosylated, (11,12) H. polymorpha/CoMed8-MATα-IFNγ – CoMed14-CNE, (15,16) H. polymorpha/CoMed8-MATα-IFNγ – CoMed14-CNE – deglycosylated.


The CoMed™ vector system is a versatile system built up in a modular way. Modules comprise of ARS sequences, rDNA targeting sequences and dominant or complementation selection markers. For expression cassettes, a choice of promoters from various sources is available, separated in the module by a MCS from an S. cerevisiae-derived PHO5 terminator.

A combination of an rDNA integration sequence and a suitable selection marker enables transformation of host strains derived from a wide range of yeast species. The vectors can easily be transformed into traditional species-specific vectors.

A single type of plasmid or multiple types of plasmids can simultaneously be integrated into the genome of the various hosts.

The vector system thus provides a powerful tool to transform several yeasts in parallel at an early stage of a particular process development thereby avoiding potential cost- and time-consuming failures.

Materials and methods

Strains and media

E. coli TOP 10 [F', mcrA, Δ(mrr-hsdRMS-mcrBC), Φ80 ΔlacZDM15, nupG, ΔlacX74, deoR, recA1, araD139, Δ(ara,leu), 7697, galU, galK, λ-, rpsL, endA1] from Invitrogen, USA, served as host strain for bacterial transformation and plasmid isolation. Strain was grown in LB medium supplemented with ampicillin (50 μg ml-1; AppliChem, Germany) when required for selection.

The yeast strains A. adeninivorans LS3 [59], A. adeninivorans 135 [32], A. adeninivorans G1211 ([aleu2 [60]), D. hansenii H158 (provided by the strain collection of UFZ, Leipzig/Germany), D. polymorphus H120 (provided by the strain collection of UFZ, Leipzig/Germany), P. pastoris GS115 (his4 – Invitrogen/USA) and the H. polymorpha MedHp1 (odc1 [14]) as well as S. cerevisiae C13ABYS86 (MATα leu2 ura3 his pra1 prb1 prc1 cps [61]) were used as hosts. All strains were grown either under non-selective conditions in complex medium (YEPD) or under selective conditions in a yeast minimal medium (YMM) supplemented with 2% of a selected carbon source [62,63]. Cultivation was performed at 30°C.

Agar plates were prepared by adding 1.6% (w/v) agar to the media. Hygromycin B (Roche Diagnostics, Germany) was added as 150 – 400 μg ml-1 when required for selection.

Yeast transformation

A.adeninivorans LS3, A.adeninivorans 135, A. adeninivorans G1211, D.hansenii H158, D.polymorphus H120, H. polymorpha MedHp1, P. pastoris GS115 and S. cerevisiae C13ABYS86 were transformed according to [25,64]. Stable transformants were obtained after a sequence of passages on selective and non-selective media. After transformation of plasmids with the hph selection marker, hygromycin B-resistant colonies were selected on YEPD agar plates supplemented with 150 – 400 mg l-1 hygromycin B (200 mg l-1 for A.adeninivorans LS3 and 135, 250 mg l-1 for D.hansenii H158 and D.polymorphus H120, 400 mg l-1 for H. polymorpha MedHp1, 150 mg l-1 for P. pastoris GS115and S. cerevisiae C13ABYS86). Single colonies were isolated and grown on YEPD medium and hygromycin B at 30°C for 2 days. This step was repeated three times before the cells were plated on non-selective YEPD agar and grown for 3–5 days at 30°C. A single colony from each transformant was isolated and defined as a strain.

In case of auxothrophy complementation the transformants were selected on YMM agar plates lacking the respective amino acid.

Isolation and characterisation of nucleic acids

Plasmid DNA, restriction fragment isolation, labeling of fragments and Southern transfer were carried out as previously described by [32,65].

Protein analysis

SDS-PAGE with 6 μg cell extract protein and Western blots were performed as described by [66]. The dye binding method of Bradford [67] was used for quantitative determination of protein concentration in cell extract with bovine serum albumin as a standard protein. IL-6 and IFNγ were immunologically detected by Western blot analysis using specific anti-IL-6 or IFNγ antibodies (R&D systems/USA) for detection. Blots were stained with Western Blue Stabilized Substrate (Promega, Germany).

IFNγ samples were digested with PNGaseF (Boehringer, Mannheim) following the instructions of the supplier. Untreated and digested samples were separated and visualized as described before.

Fluorescence microscopy

GFP expression was visualized in yeast cells by fluorescence microscopy (Axioskop, Zeiss Jena, Germany; excitation at 470 nm and detection using the BP500–530 nm emission filter). These conditions allowed visualization of GFP-mediated fluorescence avoiding a significant auto-fluorescence background. Single images (512 × 512 pixels) were collected using line-averaging eight times, each for 1 s.

Measurement of yeast dry mass and PHA

PHA, detected using gas chromatography/mass spectrometry, and yeast dry mass were measured as described by [68,69].

Estrogenic activity assay

A. adeninivorans G1211 transformed with the plasmids pAL-HPH-hERα and pAL-ALEU2m-GAA(xERE)-phyK (G1211/pAL-HPH-hERα – pAL-ALEU2m-GAA(xERE)-phyK) was the bio component of the assay. These cells were cultured in YMM with 2% glucose at 30°C for 48 h and stored as 50 μl aliquots. For detection of estrogenic activity, 950 μl of the samples were supplemented with 2% maltose (final concentration) and 50 μl of stationary yeast cell suspension (final OD600 nm = 1) was added. The suspension was cultured for 30 h at 30°C on a shaker.

Subsequently all samples were centrifuged for 10 min at 5000 × g to separate the cells from the cultivation medium. The extracellularly accumulated phytase activity was assessed through a modified method initially described by [70,71]. Aliquots (25 μl) of the supernatant samples were incubated with 25 μl 0.1 M sodium-citrate (pH 3.9) containing 3.5 mM 4-nitrophenyl phosphate for 60 min at 37°C in microtitre plates. The reaction was stopped by adding 50 μl 15% TCA. After adding of 100 μl 1 N sodium hydroxide, 4-nitrophenol was measured at 405 nm with the reader "Sunrise" from Tecan (USA) [45].


CoMed is a trade name (abbreviation of Construction set PharmedArtis).

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

GS, EB, AS and KT carried out the experiments and participated in draft a document describing the work at hand. GK and GG designed the work, completed the experiments, and wrote the manuscript. All authors read and approved the final manuscript.


The authors thank R. Franz, R. Losse, I. Schmeling and H. Bohlmann for excellent technical assistance. The research work was supported by grants from the Ministry of Science and Research (Grant No. 02WU 0168), the Ministry of Economic, Nordrhein-Westfalen (TPW-9910v08), the Deutsche Bundesstiftung Umwelt (AZ 13048) and by Funds of Chemical Industry (GK).

Parts of the results presented here have been communicated at the 4th Recombinant Protein Production Meeting (Barcelona, 2006), a detailed description of the impact of CNE1 and other secretory pathway genes has been provided at the conference for 30th anniversary of the Korean Society for Microbiology, Muju, 2003 and at the 11th ICY, Rio de Janeiro, August 2004.


  1. Gellissen G: Production of recombinant proteins – Novel microbial and eukaryotic expression systems. Weinheim: Wiley-VCH; 2005. OpenURL

  2. Gellissen G, Strasser AWM, Suckow M: Key and criteria to the selection of an expression platform. In Production of recombinant proteins – Novel microbial and eukaryotic expression systems. Edited by Gellissen G. Weinheim:Wiley-VCH; 2005:1-5. OpenURL

  3. Melmer G: Biopharmaceuticals and the industrial environment. In Production of recombinant proteins – Novel microbial and eukaryotic expression systems. Edited by Gellissen G. Weinheim: Wiley-VCH; 2005:361-383. OpenURL

  4. Harford N, Cabezon T, Colau B, Delisse A-M, Rutgers T, de Wilde M: Construction and characterization of a Saccharomyces cerevisiae strain (RIT4376) expressing hepatitis B surface antigen.

    Postgrad Med J 1987, 63:65-70. PubMed Abstract OpenURL

  5. Gellissen G: Heterologous protein production in methylotrophic yeasts.

    Appl Microbiol Biotechnol 2000, 54:741-750. PubMed Abstract | Publisher Full Text OpenURL

  6. Kang HA, Gellissen G: Hansenula polymorpha. In Production of recombinant proteins – Novel microbial and eukaryotic expression systems. Edited by Gellissen G. Weinheim: Wiley-VCH; 2005:111-142. OpenURL

  7. Ilgen C, Lin-Cereghino J, Cregg JM: Pichia pastoris. In Production of recombinant proteins – Novel microbial and eukaryotic expression systems. Edited by Gellissen G. Weinheim: Wiley-VCH; 2005:143-162. OpenURL

  8. Terentiev Y, Gellissen G, Kunze G: Arxula adeninivorans – a non-conventional dimorphic yeast of great biotechnological potential.

    Recent Res Devel Appl Microbiol Biotechnol 2003, 1:135-145. OpenURL

  9. Böer E, Gellissen G, Kunze G: Arxula adeninivorans. In Production of recombinant proteins – Novel microbial and eukaryotic expression systems. Edited by Gellissen G. Weinheim: Wiley-VCH; 2005:89-110. OpenURL

  10. Hamilton SR, Bobrowicz P, Bobrowicz B, Davidson RC, Li H, Mitchell T, Nett JH, Rausch S, Stadheim TA, Wischnewski H, Wildt S, Gerngross TU: Production of complex human glycoproteins in yeast.

    Science 2003, 301:1244-1246. PubMed Abstract | Publisher Full Text OpenURL

  11. Kim MW, Kim EJ, Kim J-Y, Park J-S, Oh D-B, Shimma J-I, Chiba Y, Jigami Y, Rhee SK, Kang HA: Functional characterization of the Hansenula polymorpha HOC1, OCH1, and OCR1 genes as members of the yeast OCH1 mannosyltransferase family involved in protein glycosylation.

    J Biol Chem 2006, 281:6261-6272. PubMed Abstract | Publisher Full Text OpenURL

  12. Ramezani-Rad M, Hollenberg CP, Lauber J, Wedler H, Griess E, Wagner C, Albermann K, Hani J, Piontek M, Dahlems U, Gellissen G: The Hansenula polymorpha (strain CBS4732) genome sequencing and analysis.

    FEMS Yeast Res 2003, 4:207-215. PubMed Abstract | Publisher Full Text OpenURL

  13. Oh KS, Kwon O, Oh YW, Sohn MJ, Jung S, Kim YK, Kim MG, Rhee SK, Gellissen G, Kang HA: Fabrication of a partial genome microarray of the methylotrophic yeast Hansenula polymorpha : optimization and evaluation for transcript profiling.

    J Microbiol Biotechnol 2004, 14:1239-1248. OpenURL

  14. Gellissen G, Kunze G, Gaillardin C, Cregg JM, Berardi E, Veenhuis M, van der Klei IJ: New yeast expression platforms based on methylotrophic Hansenula polymorpha and Pichia pastoris and on dimorphic Arxula adeninivorans and Yarrowia lipolytica – a comparison.

    FEMS Yeast Res 2005, 5:1079-1096. PubMed Abstract | Publisher Full Text OpenURL

  15. Madzak C, Nicaud J-M, Gaillardin C: Yarrowia lipolytica. In Production of recombinant proteins – Novel microbial and eukaryotic expression systems. Edited by Gellissen G. Weinheim: Wiley-VCH; 2005:163-189. OpenURL

  16. Klabunde J, Kunze G, Gellissen G, Hollenberg CP: Integration of heterologous genes in several yeast species using vectors containing a Hansenula polymorpha-derived rDNA targeting element.

    FEMS Yeast Res 2003, 4:185-193. PubMed Abstract | Publisher Full Text OpenURL

  17. Terentiev Y, Pico AH, Böer E, Wartmann T, Klabunde J, Breuer U, Babel W, Suckow M, Gellissen G, Kunze G: A wide-range integrative yeast expression system based on Arxula adeninivorans-derived elements.

    J Ind Microbiol Biotechnol 2004, 31:223-228. PubMed Abstract | Publisher Full Text OpenURL

  18. Klabunde J, Kunze G, Gellissen G, Hollenberg CP: Wide-range integrative expression vectors for fungi, based on ribosomal DNA elements. In Production of recombinant proteins – Novel microbial and eukaryotic expression systems. Edited by Gellissen G. Weinheim: Wiley-VCH; 2005:273-286. OpenURL

  19. Steinborn G, Gellissen G, Kunze G: Assessment of Hansenula polymorpha and Arxula adeninivorans-derived rDNA-targeting elements for the design of Arxula adeninivorans expression vectors.

    FEMS Yeast Res 2005, 5:1047-1054. PubMed Abstract | Publisher Full Text OpenURL

  20. Wartmann T, Stoltenburg R, Böer E, Sieber H, Bartelsen O, Gellissen G, Kunze G: The ALEU2 gene – a new component for an Arxula adeninivorans-based expression platform.

    FEMS Yeast Res 2003, 3:223-232. PubMed Abstract | Publisher Full Text OpenURL

  21. Wartmann T, Bellebna C, Böer E, Bartelsen O, Gellissen G, Kunze G: The constitutive AHSB4 promoter – a novel component of the Arxula adeninivorans-based expression platform.

    Appl Microbiol Biotechnol 2003, 62:528-535. PubMed Abstract | Publisher Full Text OpenURL

  22. Beggs JP, Guerineau M, Atkins JF: A map of the restriction targets in yeast 2 micron plasmid DNA cloned on bacteriophage lambda.

    Mol Gen Genet 1976, 17:287-294. OpenURL

  23. Gullov K, Friis J: Maintenance and copy number control of ARS1 plasmids in Saccharomyces cerevisiae. Evidence of a mating type effect.

    Curr Genet 1985, 10:21-27. PubMed Abstract OpenURL

  24. Piontek M, Hagedorn J, Hollenberg CP, Gellissen G, Strasser AWM: Two novel gene expression systems based on the yeasts Schwanniomyces occidentalis and Pichia stipitis.

    Appl Microbiol Biotechnol 1998, 50:331-338. PubMed Abstract | Publisher Full Text OpenURL

  25. Rösel H, Kunze G: Integrative transformation of the dimorphic yeast Arxula adeninivorans based on hygromycin B resistance.

    Curr Genet 1998, 33:157-163. PubMed Abstract | Publisher Full Text OpenURL

  26. Rose M, Grisafi P, Botstein D: Structure and function of the yeast URA3 gene: expression in Escherichia coli.

    Gene 1984, 29:113-124. PubMed Abstract | Publisher Full Text OpenURL

  27. Froman BE, Tait RC, Rodriguez RL: Nucleotide sequence of the 3' terminal region of the LEU2 gene from Saccharomyces cerevisiae.

    Gene 1984, 31:257-261. PubMed Abstract OpenURL

  28. Thill GP, Davis GR, Stillman C, Holtz G, Brierley R, Engel M, Buckholtz R, Kenney J, Provow S, Vedvick T, Siegel RS: Positive and negative effects of multicopy integrated expression vectors on protein expression in Pichia pastoris. In Proceedings of the 6th International Syposium on the genetics of microorganisms. Edited by Heslot H, Davies J, Florent J, Bobichon L, Durand G, Penasse L. Paris: Société Francaise de Microbiologie; 1990:477-490. OpenURL

  29. Steinborn G, Wartmann T, Gellissen G, Kunze G: Construction of an Arxula adeninivorans host-vector system based on trp1 complementation.

    J Biotechnol 2006, in press. PubMed Abstract | Publisher Full Text OpenURL

  30. Amuel C, Gellissen G, Hollenberg CP, Suckow M: Analysis of heatshock promoters in Hansenula polymorpha : TPS1, a novel element for heterologous gene expression.

    Biotechnol Bioprocess Eng 2000, 5:247-252. OpenURL

  31. Raschke WC, Neiditsch BR, Hendricks M, Cregg JM: Inducible expression of a heterologous protein in Hansenula polymorpha using the alcohol oxidase I promoter of Pichia pastoris.

    Gene 1996, 177:163-187. PubMed Abstract OpenURL

  32. Wartmann T, Böer E, Huarto Pico A, Sieber H, Bartelsen O, Gellissen G, Kunze G: High-level production of recombinant proteins by the dimorphic yeast Arxula adeninivorans .

    FEMS Yeast Res 2002, 2:363-369. PubMed Abstract | Publisher Full Text OpenURL

  33. Bui DM, Kunze I, Förster S, Wartmann T, Horstmann C, Manteuffel R, Kunze G: Cloning and expression of an Arxula adeninivorans glucoamylase gene in Saccharomyces cerevisiae.

    Appl Microbiol Biotechnol 1996, 44:610-619. OpenURL

  34. Böer E, Mock HP, Bode R, Gellissen G, Kunze G: Anextracellular lipase from the dimorphic yeast Arxula adeninivorans. Molecular cloning of the ALIP1 gene and characterization of the purified recombinant enzyme.

    Yeast 2005, 22:523-535. PubMed Abstract | Publisher Full Text OpenURL

  35. Böer E, Wartmann T, Luther B, Manteuffel R, Bode R, Gellissen G, Kunze G: Characterization of the AINV gene and the encoded invertase from the dimorphic yeast Arxula adeninivorans.

    Antonie van Leeuwenhoek 2004, 86:121-134. PubMed Abstract | Publisher Full Text OpenURL

  36. Böer E, Wartmann T, Schmidt S, Bode R, Gellissen G, Kunze G: Characterization of the AXDH gene and the encoded xylitol dehydrogenase from the dimorphic yeast Arxula adeninivorans.

    Antonie van Leeuwenhoek 2004, 87:233-243. OpenURL

  37. Müller S, Sandal T, Kamp-Hansen P, Dalboge H: Comparison of expression systems in the yeasts Saccharomyces cerevisiae, Hansenula polymorpha, Kluyveromyceslactis, Schizosaccharomyces pombe and Yarrowialipolytica. Cloning of two novel promoters from Yarrowia lipolytica.

    Yeast 1998, 14:1267-1283. PubMed Abstract | Publisher Full Text OpenURL

  38. Tonouchi N, Oouchi N, Kashima N, Kawai M, Nagase K, Okano A, Matsui H, Yamada K, Hirano T, Kishimoto T: High-level expression of BSF2/IL6 cDNA in Escherichia coli using a new type of expression/preparation system.

    J Biochem 1988, 104:30-34. PubMed Abstract OpenURL

  39. Guisez Y, Tison B, Vanderkerckhove J, Demolder J, Bauw G, Haegemann G, Fiers W, Contreras R: Production and purification of recombinant interleukin-6 secreted by the yeast Saccharomyces cerevisiae.

    Eur J Biochem 1991, 198:217-222. PubMed Abstract OpenURL

  40. Degelmann A, Müller F, Sieber H, Jenzelewski V, Suckow M, Strasser AWM, Gellissen G: Strain and process development for the production of human cytokines in Hansenula polymorpha .

    FEMS Yeast Res 2002, 2:349-361. PubMed Abstract | Publisher Full Text OpenURL

  41. Gellissen G, Müller F, Sieber H, Tieke A, Jenzelewski V, Degelmann A, Strasser AWM: Production of cytokines in Hansenula polymorpha. In Hansenula polymorpha – biology and applications. Edited by Gellissen G. Weinheim: Wiley-VCH; 2002:229-254. OpenURL

  42. Proudfoot AE, Brown SC, Bernard AR, Bonnefoy JY, Kawashima EH: Recombinant human IL-6 expressed in E. coli undergoes selective N-terminal degradation: evidence that the protein consists of a stable core and a non-essential N-terminal.

    J Protein Chem 1993, 12:489-497. PubMed Abstract OpenURL

  43. Klabunde J, Diesel A, Waschk D, Gellissen G, Hollenberg CP, Suckow M: Single-step co-integration of multiple expressible heterologous genes into the ribosomal DNA of the methylotrophic yeast Hansenula polymorpha .

    Appl Microbiol Biotechnol 2002, 58:797-805. PubMed Abstract | Publisher Full Text OpenURL

  44. Terentiev Y, Breuer U, Babel W, Kunze G: Non-conventional yeasts as producers of polyhydroxylalkanoates: genetic engineering of Arxula adeninivorans .

    Appl Microbiol Biotechnol 2004, 64:376-381. PubMed Abstract | Publisher Full Text OpenURL

  45. Hahn T, Tag K, Riedel K, Uhlig S, Baronian K, Gellissen G, Kunze G: A novel estrogen sensor based on recombinant Arxula adeninivorans cells.

    Biosensors Bioelectronics 2006, 21:2078-2085. PubMed Abstract | Publisher Full Text OpenURL

  46. Key LL, Ries WL, Rodriguiz RM, Hatcher HC: Recombinant interferon-gamma therapy for osteopetrosis.

    J Pediatr 1992, 121:119-124. PubMed Abstract OpenURL

  47. Key LL, Rodriguiz RM, Willi SM, Wright NM, Hatcher HC, Eyre DR, Cure JK, Griffin PP, Ries WL: Long-term treatment of osteopetrosis with human interferon-gamma.

    N Engl J Med 1995, 332:1594-1599. PubMed Abstract | Publisher Full Text OpenURL

  48. Arakawa T, Hsu YR, Chang D, Stebbing N, Altrock B: Structure and activity of human interferon-gamma.

    J Interferon Res 1986, 6:687-695. PubMed Abstract OpenURL

  49. Saraneva T, Pirhonen J, Cantell K, Julkonen I: N-glycosylation of interferon-gamma: glycans at Asn25 are critical for protease resistance.

    Biochem J 1995, 308:9-14. PubMed Abstract | PubMed Central Full Text OpenURL

  50. Simons G, Remaut E, Allet B, Devos R, Fiers W: High-level expression of human interferon-gamma in Escherichia coli under control of the pL promoter of bacteriophage lambda.

    Gene 1984, 28:55-64. PubMed Abstract | Publisher Full Text OpenURL

  51. Nishi T, Fujita T, Nishi-Takaoka C, Saito A, Matsumoto T, Sato M, Oka T, Itoh S, Yip YK, Vilcek J: Cloning and expression of a novel variant of human interferon-gamma cDNA.

    J Biochem 1985, 97:153-159. PubMed Abstract OpenURL

  52. Riske FJ, Cullen BR, Chizzonite R: Characterization of human interferon-gamma and human interleukin-2 from recombinant mammalian cell lines and peripheral blood lymphozytes.

    Lymphokine Cytokine Res 1991, 10:213-218. PubMed Abstract OpenURL

  53. Harmsen MM, Bruyne MI, Raue HA, Maat J: Overexpression of binding protein and disruption of the PMR1 gene synergistically stimulate secretion of bovine prochymosin but not plant thaumatin in yeast.

    Appl Microbiol Biotechnol 1996, 46:365-370. PubMed Abstract | Publisher Full Text OpenURL

  54. Bao WG, Fukuhara H: Secretion of human proteins from yeast: stimulation by duplication of polyubiquitin and protein disulfideisomerase genes in Kluyveromyces lactis .

    Gene 2001, 272:103-110. PubMed Abstract | Publisher Full Text OpenURL

  55. Ruohonen L, Toikkanen J, Tieaho V, Outola M, Soderlund H, Keranen S: Enhancement of protein secretion in Saccharomyces cerevisiae by overproduction of SSO protein, a late-acting component of the secretory machinery.

    Yeast 1997, 13:337-351. PubMed Abstract | Publisher Full Text OpenURL

  56. Farwick M: Untersuchungen der Produktausbeute bei der Sekretion heterologer Proteine durch S. cerevisiae . PhD thesis. HHU Düsseldorf; 1998. OpenURL

  57. Müller F, Tieke A, Waschk D, Mühle C, Müller F, Seigelchifer M, Pesce A, Jenzelewski V, Gellissen G: Production of IFNα-2a in Hansenula polymorpha .

    Process Biochem 2002, 38:15-25. OpenURL

  58. Klabunde J: Koproduktion pharmazeutischer Proteine und Hilfsfaktoren zur Optimierung mikrobieller Expressionssysteme bei Beschränkung auf ein einziges integratives Vektorsystem. PhD thesis. HHU Düsseldorf; 2003. OpenURL

  59. Kunze G, Kunze I: Characterization of Arxula adeninivorans strains from different habitats.

    Antonie van Leeuwenhoek 1994, 65:29-34. PubMed Abstract OpenURL

  60. Samsonova IA, Kunze G, Bode R, Böttcher F: A set of genetic markers for the chromosomes of the imperfect yeast Arxula adeninivorans.

    Yeast 1996, 12:1209-1217. PubMed Abstract OpenURL

  61. Heinemeyer W, Kleinschmidt JA, Saidowsky J, Escher C, Wolf DH: Proteinase yscE, the yeast proteasome/multicatalytic-multifunctional proteinase: mutants unravel its function in stress induced proteolysis and uncover its necessity for cell survival.

    EMBO J 1991, 10:555-562. PubMed Abstract | PubMed Central Full Text OpenURL

  62. Rose MD, Winston F, Hieter P: Methods in Yeast Genetics. A Laboratory Manual. Cold Spring Harbor New York: Cold Spring Harbor Laboratory Press; 1990. OpenURL

  63. Tanaka A, Ohnishi N, Fukui S: Studies on the formation of vitamins and their function in hydrocarbon fermentation. Production of vitamin B6 by Candida albicans in hydrocarbon medium.

    J Ferment Technol 1967, 45:617-623. OpenURL

  64. Dohmen RJ, Strasser AW, Höner CB, Hollenberg CP: An efficient transformation procedure enabling long-term storage of competent cells of various yeast genera.

    Yeast 1991, 7:691-692. PubMed Abstract OpenURL

  65. Wartmann T, Erdmann J, Kunze I, Kunze G: Morphology-related effects on gene expression and protein accumulation of the yeast Arxula adeninivorans LS3.

    Arch Microbiol 2000, 173:253-261. PubMed Abstract | Publisher Full Text OpenURL

  66. Kunze I, Hensel G, Adler K, Bernard J, Neubohn B, Nilsson C, Stoltenburg R, Kohlwein SD, Kunze G: The green fluorescent protein targets secretory proteins to the yeast vacuole.

    Biochim Biophys Acta 1999, 1410:287-298. PubMed Abstract | Publisher Full Text OpenURL

  67. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

    Anal Biochem 1976, 72:248-254. PubMed Abstract | Publisher Full Text OpenURL

  68. Riis V, Mai W: Gas chromatographic determination of poly-β-hydroxybutyric acid in microbial biomass after hydrochloric acid propanolysis.

    J Chromatogr 1988, 445:285-289. OpenURL

  69. Breuer U, Ackermann JU, Babel W: Accumulation of poly(3-hydroxybutyric acid) and overproduction of exopolysaccharides in a mutant of a methylotrophic bacterium.

    Can J Microbiol 1995, 41(Suppl 1):55-59. OpenURL

  70. Büttner R, Bode R, Birnbaum D: Characterization of extracellular acid phosphatases from the yeast Arxula adeninivorans.

    Zentralbl Mikrobiol 1991, 146:399-406. OpenURL

  71. Sajidan A, Farouk A, Greiner R, Jungblut P, Müller EC, Borriss R: Molecular and physiological characterisation of a 3-phytase from soil bacterium Klebsiella sp. ASR1.

    Appl Microbiol Biotechnol 2004, 65:110-118. PubMed Abstract | Publisher Full Text OpenURL